This article is more than 5 years old. Information may no longer be current.

Enzymatic vitreolysis could mark beginning of new era in treating vitreomacular interface diseases

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Pharmacotherapy may set a new standard of care for symptomatic vitreomacular adhesion and vitreomacular traction-related macular hole, according to recent findings. Read more in the October issue of OSN Europe Edition. Get the whole story